Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

New precision medicine venture gives Syngenis added firepower

The venture will commercialise RosaMind first, which reads eight genes and guides prescribing across more than 20 medicines for mental health conditions.

Summary by Sydney Morning Herald
Syngenis has joined Perron Institute and Gene S founders in a new precision-medicine venture that puts its integrated DNA and RNA biotech platform to work.

4 Articles

Sydney Morning HeraldSydney Morning Herald
+3 Reposted by 3 other sources
Lean Left

New precision medicine venture gives Syngenis added firepower

Syngenis has joined Perron Institute and Gene S founders in a new precision-medicine venture that puts its integrated DNA and RNA biotech platform to work.

·North Sydney, Australia
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 75% of the sources lean Left
75% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Sydney Morning Herald broke the news in North Sydney, Australia on Wednesday, September 23, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

DNA icon

DNA

Melbourne, Australia icon

Melbourne, Australia

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal